Thursday, 07 July 2022

Pfizer’s support to Tata Trusts Cancer Care prog helps screen close to 70,000 people for NCDs, cancer

21 February 2022 | News

The programme is currently running in Diphu and Silchar in Assam and, additionally, in Ranchi, Jharkhand, and Tirupati, Andhra Pradesh

Image credit: Shutterstock

Image credit: Shutterstock

Pfizer announced that its support to Tata Trusts Cancer Care programme since 2020 has helped in enrolling and screening 70,000 people for non-communicable diseases (NCDs) and cancer across Assam, Jharkhand and Andhra Pradesh. Pfizer partnered with Tata Trusts’ Special Purpose Vehicle, Alamelu Charitable Foundation (ACF) for their Cancer Care Programme to help set up health and wellness kiosks, facilitate community screening and a virtual patient helpdesk, and assist in the training of ASHA and Anganwadi workers in Diphu and Silchar in Assam and, additionally, in Ranchi, Jharkhand, and Tirupati, Andhra Pradesh.

 

S Sridhar, MD, Pfizer, “Our partnership with the Tata Trusts Cancer Care Programme has helped us truly support patients from early detection, through the care continuum, to help ensure that their treatment outcomes are the best possible. We are proud of the outcomes we have achieved in the first year and look forward to expanding this program within Assam; to other cities in the North-East; and to the rest of India.”

 

Dr Sanjiv Chopra, Chief Executive, Cancer Care Programme, Tata Trusts, said, “Our partnership with Pfizer has been helping us to deliver the care and support that is needed to help reduce the burden of cancer in select states. Through our collaborative efforts, we hope to continue improving the lives of many.” 

 

 

 

 

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account